NASDAQ · NTRA
Natera, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NTRA: Nov 05, 2026
Natera, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.17. The reported EPS for the same quarter last year was $-0.64.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.17 | $0.13 | $-0.38 | 4 |
| Dec 2026 | $0.01 | $0.31 | $-0.13 | 4 |
| Mar 2027 | $-0.18 | $-0.15 | $-0.25 | 4 |
| Jun 2027 | $-0.11 | $-0.08 | $-0.13 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · Fintel · BNK Invest- Zacks · Oct 29, 6:05 PM EDTCareDx (CDNA) Surpasses Q3 Earnings and Revenue EstimatesCareDx (CDNA) delivered earnings and revenue surprises of +191.67% and +13.90%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 29, 9:00 AM EDTNatera (NTRA) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseNatera (NTRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 28, 9:30 AM EDTNTRA Q3 Earnings on Deck: Will Signatera Volume Growth Drive Results?Natera's third-quarter 2026 results hinge on Signatera volume growth, regulatory milestones and higher test prices, while expanding Medicare coverage may boost organ health revenues.
- The Motley Fool · Oct 25, 10:05 PM EDTStanley Druckenmiller Has Bet Big on This 1 Healthcare Stock. Here's Why I Disagree.Druckenmiller owns a large stake in Natera.
- Fintel · Oct 22, 11:54 PM EDTNatera Consensus Price Target Raised by 10.36% to $398.33The average one-year price target for Natera (NASDAQGS:NTRA) (DB:45E) has been revised to $398.33 / share, an increase of 10.36% from the prior estimate of $360.94 dated September 29, 2026.These figures represent aggregate analyst targets and do not constitute a recommendation by
- BNK Invest · Oct 21, 10:57 AM EDTIBB, REGN, NTRA, ARGX: Large Outflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an approximate $200.0 million dollar outflow — that's a 1.8% decrease week over week
- Zacks · Oct 21, 9:16 AM EDTNatera Partners With TransCode to Advance Colorectal Cancer TrialNTRA partners with TransCode Therapeutics to use Signatera MRD testing in a Phase 2a colorectal cancer trial, aiming to accelerate enrollment and research.
- BNK Invest · Oct 20, 6:40 AM EDTNTRA Crosses Above Average Analyst TargetIn recent trading, shares of Natera Inc (Symbol: NTRA) have crossed above the average analyst 12-month target price of $397.30, changing hands for $399.42/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
- Zacks · Oct 15, 8:28 AM EDTNatera Gains 118.1% in a Year: What's Driving the Rally?NTRA shares surge 118.1% in a year, fueled by robust Signatera adoption, expanding test volumes and improving margins, despite competition and rising costs.
- RTTNews · Oct 13, 9:15 AM EDTNatera, TransCode Target Residual Colorectal Cancer With Trial Collaboration(RTTNews) – Natera, Inc. (NTRA) and TransCode Therapeutics, Inc. (RNAZ) have entered into a strategic collaboration to support patient enrollment in TransCode's Phase 2a trial evaluating TTX-MC138 in colorectal cancer (CRC).
- BNK Invest · Oct 12, 11:52 AM EDTiShares Biotechnology ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an approximate $330.4 million dollar outflow — that's a 3.0% decrease week over week
- Zacks · Oct 12, 10:46 AM EDTTempus AI Expands Strategic Collaborations to Drive Future GrowthTEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future revenue growth.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Natera, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.